Ministers are reviewing a controversial medicine tax that pharmaceutical companies say makes Britain 'uninvestable' as part ...

Britain said a single case of atypical Bovine Spongiform Encephalopathy (BSE) had been confirmed on a farm in England and the ...

German vaccine maker BioNTech said on Tuesday that it plans to invest up to 1 billion pounds ($1.33 billion) over the next ...

A number of US pharmaceutical groups have recently made announcements about expanding domestic manufacturing. These include ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

Last week, Relonchem had secured another market authorisation for its Gabapentin oral solution, 50 mg/ml, from the UKMHRA. It ...

DRUG giants were put on notice by Donald Trump yesterday that he would be slashing prices for medicines in the US to the cheapest available. The move is another blow for Britain’s drug giants ...

The company said its subsidiary Relonchem Ltd received marketing authorisation from the UK Medicines and Healthcare products ...

The President threatened to slap a 25 per cent tariff on UK pharmaceuticals entering the US, which last year totalled £6.6 billion. But last week's deal promised the sector 'significantly ...